APO-AMITRIPTYLINE 10mg: NDMA impurity
Critical priority
What you should do
- 1Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication.
- 2Stopping amitriptyline may lead to mild withdrawal symptoms.
- 3Contact your health care provider if you have taken a recalled product and you have concerns about your health.
- 4Ask your pharmacist if you are unsure whether you are taking a recalled product.
- 5Contact the company if you have questions about the recall:Apotex Inc. via Sedgwick by calling at 1-888-266-7914, or by email at apotex5117@sedgwick.comAA Pharma at 1-905-669-1565Report any health product-related side effects or complaints to Health Canada.
The issue
Product safety
Affected product
APO-AMITRIPTYLINE 10mg
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada — Drugs and health products
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.